东诚药业：控股子公司获得放射性药品生产许可证

Core Viewpoint - Dongcheng Pharmaceutical announced that its subsidiary, Yantai Lannacheng Biotechnology Co., Ltd., has received the "Radioactive Drug Production License" from the Shandong Provincial Drug Administration [1] Group 1 - The license allows the subsidiary to engage in the production of radioactive drugs, which may enhance its product offerings and market position [1] - This development indicates a regulatory approval that could lead to increased revenue opportunities for the company [1]